Journal of Korean Neurosurgical Society

  • 제57권6호
  • /
  • Pages.390-395
  • /
  • 2015
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data

  • Kim, Tackeun (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Lee, Heeyoung (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Bang, Jae Seung (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Kwon, O-Ki (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Hwang, Gyojun (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Oh, Chang Wan (Department of Neurosurgery, Seoul National University Bundang Hospital)
  • 투고 : 2015.01.27
  • 심사 : 2015.03.16
  • 발행 : 2015.06.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

There have been a few studies reporting the epidemiology of moyamoya disease in Korea. Previous studies revealed relatively high prevalence and incidence of moyamoya disease in Korea and Japan. This study was designed to provide the latest epidemiologic information of moyamoya disease in Korea. We analyzed a database comprising of 50 million people covered in Korea by the National Health Insurance Service to calculate the prevalence. The incidence was estimated by eliminating the duplicated records of previous 3 years. We summarized the prevalence and incidence according to age, sex, and local distribution. In addition, the chronological changes were demonstrated with direct standardization using the 2010 population structure information. The standardized prevalence was 6.5 per 100000 persons in 2005, which was increased to 18.1 in 2013. In the same period, standardized incidence was increased from 2.7 to 4.3 per 100000 persons. The prevalence for men was 4.9 and 8.3 for women in 2005. In 2013, the prevalence had increased for men and women to 13.8 and 25.3, respectively. The incidence for men and women was 2.2 and 3.2, respectively, in 2005. It had increased to 3.5 and 5.7, respectively. The mean age of patients was 33.5 in 2005 and increased to 42.5 in 2013. The peak prevalent age group had shifted slightly to the older age groups, with chronologically consistent female predominance. The prevalence was highest in Jeollabuk province and lowest in Ulsan city.

키워드

참고문헌

  1. Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS : Incidence, prevalence, and survival of moyamoya disease in Korea : a nationwide, population-based study. Stroke 45 : 1090-1095, 2014 https://doi.org/10.1161/STROKEAHA.113.004273
  2. Baba T, Houkin K, Kuroda S : Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79 : 900-904, 2008 https://doi.org/10.1136/jnnp.2007.130666
  3. Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF : Epidemiology of moyamoya disease in Taiwan : a nationwide population-based study. Stroke 45 : 1258-1263, 2014 https://doi.org/10.1161/STROKEAHA.113.004160
  4. Choi KS : Moyamoya disease in Korea. A cooperative study in Suzuki J (ed) : Advances in Surgery for Cerebral Stroke. Tokyo : Springer-Verlag, 1988, pp107-109
  5. Hung CC, Tu YK, Su CF, Lin LS, Shih CJ : Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 99 Suppl 2 : S23-S25, 1997
  6. Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M : Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99 Suppl 2 : S6-S10, 1997
  7. Im SH, Cho CB, Joo WI, Chough CK, Park HK, Lee KJ, et al. : Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg 14 : 75-78, 2012 https://doi.org/10.7461/jcen.2012.14.2.75
  8. Kleinloog R, Regli L, Rinkel GJ, Klijn CJ : Regional differences in incidence and patient characteristics of moyamoya disease : a systematic review. J Neurol Neurosurg Psychiatry 83 : 531-536, 2012 https://doi.org/10.1136/jnnp-2011-301387
  9. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. : Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 39 : 42-47, 2008 https://doi.org/10.1161/STROKEAHA.107.490714
  10. Kuroda S, Houkin K. Moyamoya disease : current concepts and future perspectives. Lancet Neurol 7 : 1056-1066, 2008 https://doi.org/10.1016/S1474-4422(08)70240-0
  11. Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A : Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo) 52 : 299-303, 2012 https://doi.org/10.2176/nmc.52.299
  12. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6 : e22542, 2011 https://doi.org/10.1371/journal.pone.0022542
  13. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, et al. : Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112 : 199-203, 2010 https://doi.org/10.1016/j.clineuro.2009.11.009
  14. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 45 : 1415-1421, 2014 https://doi.org/10.1161/STROKEAHA.113.004386
  15. Nam DH, Oh CW, Wang KC, Paek SH, Hwang YS, Kim IO, et al. : Moyamoya disease : the differences between age groups in clinical presentation and hemodynamic characteristics. J Korean Neurosurg Soc 26 : 1357-1362, 1997
  16. Natori Y, Ikezaki K, Matsushima T, Fukui M : 'Angiographic moyamoya' its definition, classification, and therapy. Clin Neurol Neurosurg 99 Suppl 2 : S168-S172, 1997
  17. Saeki N, Nakazaki S, Kubota M, Yamaura A, Hoshi S, Sunada S, et al. : Hemorrhagic type moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S196-S201, 1997
  18. Suzuki J, Kodama N : Moyamoya disease--a review. Stroke 14 : 104-109, 1983 https://doi.org/10.1161/01.STR.14.1.104
  19. Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969 https://doi.org/10.1001/archneur.1969.00480090076012
  20. Uchino K, Johnston SC, Becker KJ, Tirschwell DL : Moyamoya disease in Washington State and California. Neurology 65 : 956-958, 2005 https://doi.org/10.1212/01.wnl.0000176066.33797.82
  21. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. : Epidemiological features of moyamoya disease in Japan : findings from a nationwide survey. Clin Neurol Neurosurg 99 Suppl 2 : S1-S5, 1997 https://doi.org/10.1016/S0303-8467(97)00031-0
  22. Wetjen NM, Garell PC, Stence NV, Loftus CM : Moyamoya disease in the midwestern United States. Neurosurg Focus 5 : e1, 1998
  23. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG : Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99 Suppl 2 : S58-S60, 1997

피인용 문헌

  1. A new horizon of moyamoya disease and associated health risks explored through RNF213 vol.21, pp.2, 2015, https://doi.org/10.1007/s12199-015-0498-7
  2. A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease vol.59, pp.6, 2015, https://doi.org/10.3340/jkns.2016.59.6.537
  3. Moyamoya Disease: Treatment and Outcomes vol.18, pp.1, 2015, https://doi.org/10.5853/jos.2015.01739
  4. Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome vol.7, pp.None, 2015, https://doi.org/10.1038/s41598-017-02588-1
  5. Safety and efficacy of remote ischemic conditioning in pediatric moyamoya disease patients treated with revascularization therapy vol.3, pp.4, 2015, https://doi.org/10.4103/bc.bc_30_17
  6. Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases vol.8, pp.2, 2015, https://doi.org/10.3892/br.2017.1030
  7. Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications vol.20, pp.2, 2015, https://doi.org/10.5853/jos.2018.00150
  8. Surgical Treatment of Adult Moyamoya Disease vol.20, pp.7, 2015, https://doi.org/10.1007/s11940-018-0511-8
  9. Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-45141-y
  10. Patterns of Acute Intracranial Hemorrhage in Adult Patients with Bilateral and Unilateral Moyamoya Disease vol.16, pp.3, 2015, https://doi.org/10.2174/1567202616666190621093652
  11. Incidence of Prostate Cancer according to Metabolic Health Status: a Nationwide Cohort Study vol.34, pp.6, 2015, https://doi.org/10.3346/jkms.2019.34.e49
  12. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism vol.35, pp.2, 2019, https://doi.org/10.1007/s00381-018-3985-5
  13. Machine learning for detecting moyamoya disease in plain skull radiography using a convolutional neural network vol.40, pp.None, 2019, https://doi.org/10.1016/j.ebiom.2018.12.043
  14. Epidemiology of ruptured brain arteriovenous malformation: a National Cohort Study in Korea vol.130, pp.6, 2015, https://doi.org/10.3171/2018.1.jns172766
  15. Epidemiology of ruptured brain arteriovenous malformation: a National Cohort Study in Korea vol.130, pp.6, 2015, https://doi.org/10.3171/2018.1.jns172766
  16. Blood Oxygen Level-Dependent Response Changes in the Ipsilateral Primary Somatosensory Cortex and Thalamus of Patients With Moyamoya Disease During Median Nerve Electrical Stimulation : vol.43, pp.4, 2019, https://doi.org/10.1097/rct.0000000000000891
  17. Diagnosis and treatment of adult Moyamoya disease vol.62, pp.11, 2015, https://doi.org/10.5124/jkma.2019.62.11.577
  18. The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011–2015 vol.14, pp.None, 2019, https://doi.org/10.1186/s13023-019-1032-6
  19. Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease vol.11, pp.None, 2020, https://doi.org/10.3389/fneur.2020.00072
  20. Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease vol.11, pp.None, 2015, https://doi.org/10.3389/fneur.2020.00382
  21. Progress in moyamoya disease vol.43, pp.2, 2020, https://doi.org/10.1007/s10143-018-0994-5
  22. Stress and mood of adults with moyamoya disease: A cross‐sectional study vol.22, pp.3, 2015, https://doi.org/10.1111/nhs.12729
  23. Increased incidence of bladder cancer with metabolically unhealthy status: analysis from the National Health Checkup database in Korea vol.10, pp.None, 2015, https://doi.org/10.1038/s41598-020-63595-3
  24. Prediction of Intracranial Aneurysm Risk using Machine Learning vol.10, pp.None, 2015, https://doi.org/10.1038/s41598-020-63906-8
  25. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study vol.6, pp.4, 2015, https://doi.org/10.1136/svn-2021-000909
  26. Epidemiology of Moyamoya disease in China: A nationwide hospital-based study vol.18, pp.None, 2022, https://doi.org/10.1016/j.lanwpc.2021.100331